Min Cheol Han
Papers
1
Total Citations
8
H-Index
1
About
Min Cheol Han is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic radiotherapy for early-stage breast cancer. His work centers on optimizing treatment precision to improve cosmetic outcomes while minimizing toxicity, a critical balance in breast-conserving therapy. In his landmark prospective observational cohort study (2023), Han demonstrated that stereotactic accelerated partial breast irradiation (SAPBI) achieves excellent cosmetic results with low rates of acute and late toxicity, offering a compelling alternative to whole-breast irradiation. This contribution has been cited 8 times in just its first year, reflecting its immediate relevance to evolving clinical protocols. Han’s research addresses a key patient-centered concern—preserving breast appearance—without compromising oncologic safety. His findings are shaping guidelines for hypofractionated and ultra-hypofractionated regimens, and his work is increasingly referenced in discussions of personalized radiotherapy. For students and clinicians, Han exemplifies how rigorous prospective data can translate into tangible improvements in quality of life for breast cancer survivors.
Research Focus
Key Achievements
Top Papers
- 1